TWD
RVMD icon

True Wealth Design’s Revolution Medicines RVMD Stock Holding History

True Wealth Design’s Portfolio RVMD Stock Details RVMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$24.7K Buy
132
+127
+2,540% +$18.6K 0.01% 738
2026
Q1 		$487 Hold
5
– – ﹤0.01% 2063
2025
Q4 		$399 Sell
5
-1
-17% -$66 ﹤0.01% 2025
2025
Q3 		$281 Buy
6
+1
+20% +$39 ﹤0.01% 2211
2025
Q2 		$184 Buy
+5
New +$192 ﹤0.01% 2098

Other funds holding RVMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
DGM
Darwin Global Management St. Helier, Jersey $3.76B AUM 342.13% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
NI
Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return

True Wealth Design's RVMD Position: Q2 2026 in Review

True Wealth Design increased its Revolution Medicines (RVMD) stake by 2,540% in Q2 2026, buying an estimated $18.6K and bringing the position to 132 shares worth $24.7K. The position accounts for 0.01% of the portfolio, ranked #738.

True Wealth Design first reported a position in RVMD in Q2 2025 and has held it in 5 quarters since. 690 funds tracked by Wall St. Rank hold RVMD as of Q2 2026.

  • True Wealth Design held 132 shares of Revolution Medicines worth $24.7K as of Q2 2026.
  • True Wealth Design bought 127 Revolution Medicines shares in Q2 2026, an estimated $18.6K.
  • Revolution Medicines made up 0.01% of True Wealth Design's portfolio in Q2 2026, its #738 holding.
  • True Wealth Design first reported a position in Revolution Medicines in Q2 2025 and has held it in 5 quarters since.
  • 690 funds tracked by Wall St. Rank held Revolution Medicines as of Q2 2026.

Based on True Wealth Design's 13F filing for Q2 2026, filed 16 Jul 2026.